Beacon Pointe Advisors, LLC

SEC CIK: 0001744317
Latest filing: Aug 18, 2026

SEC filings (opens in a new tab)

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Beacon Pointe Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overview All 13F holders of VRTX Full Q2 2026 holdings

Shares (Q2 2026): 17,047
Value: $8.47M
% of portfolio: <0.1%
Quarters held: 22; Since Q1 2021

Holdings of VRTX by Beacon Pointe Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	17,047	$8.47M	<0.1%	−847−4.7%	Reduced	Holders
Q1 2026	17,894	$7.99M	<0.1%	+4,392+32.5%	Added	Holders
Q4 2025	13,502	$6.12M	<0.1%	+218+1.6%	Added	Holders
Q3 2025	13,284	$5.20M	<0.1%	−2,745−17.1%	Reduced	Holders
Q2 2025	16,029	$7.14M	0.1%	−196−1.2%	Reduced	Holders
Q1 2025	16,225	$7.87M	0.1%	+22+0.1%	Added	Holders
Q4 2024	16,203	$6.52M	0.1%	−793−4.7%	Reduced	Holders
Q3 2024	16,996	$7.90M	0.1%	−2,185−11.4%	Reduced	Holders
Q2 2024	19,181	$8.99M	0.1%	−80.0%	Reduced	Holders
Q1 2024	19,189	$8.02M	0.1%	−75−0.4%	Reduced	Holders
Q4 2023	19,264	$7.84M	0.1%	−813−4.0%	Reduced	Holders
Q3 2023	20,077	$6.98M	0.1%	+724+3.7%	Added	Holders
Q2 2023	19,353	$6.81M	0.1%	−1,753−8.3%	Reduced	Holders
Q1 2023	21,106	$6.65M	0.1%	−5,230−19.9%	Reduced	Holders
Q4 2022	26,336	$7.61M	0.1%	−546−2.0%	Reduced	Holders
Q3 2022	26,882	$7.79M	0.2%	−297−1.1%	Reduced	Holders
Q2 2022	27,179	$7.66M	0.2%	−753−2.7%	Reduced	Holders
Q1 2022	27,932	$7.29M	0.1%	+5,414+24.0%	Added	Holders
Q4 2021	22,518	$4.95M	0.1%	−6,314−21.9%	Reduced	Holders
Q3 2021	28,832	$5.23M	0.1%	+17,845+162.4%	Added	Holders
Q2 2021	10,987	$2.21M	0.1%	+9,536+657.2%	Added	Holders
Q1 2021	1,451	$313.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.